Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry

被引:0
作者
Salas, Sofia P.
Osorio F, Marcial
Vial C, Pablo
Rehbein, Ana Maria, V
Salas A, Camila
Pablo Beca, Juan
机构
[1] Pontificia Univ Catolica Chile, Dept Obstet & Ginecol, Escuela Med, Santiago, Chile
[2] Univ Desarrollo, Fac Med, Clin Alemana, Ctr Bioet, Santiago, Chile
关键词
delivery of health care; ethics; medical; drug industry;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sometimes, the prescription practice of physicians can be influenced by factors that are not related to scientific evidence due to the appearance of several conflicts of interest. These conflicts cause social concern and have prompted actions to regulate the ethics of individual and corporative activities related to healthcare. We analyzed the ethical problems involved in the physician-industry relationship. For this purpose, we considered as the main actors related to this problem, the pharmaceutical industry and their marketing strategies, medical doctors and the independence and objectivity that should guide prescriptions and, finally patients and their right to receive prescriptions based oil scientific evidence. From the point of view of the Bioethics principles, Beneficence would not be respected when gifts or other donations received from the industry affect doctor's independence. Non Maleficence principle could be jeopardized if there is an increased risk of treatment failure and finally Justice could be altered if there is a cost increase for either patients or health institutions. As a conclusion, we consider that the presence of conflicts of interest in the relationship of physicians with the pharmaceutical industry is all important ethical problem. In consequence, this group endorses the recommendations of the Chilean Association of Medical Scientific Societies and advices to include ethical guidelines on this topic in the curriculum of medical schools.
引用
收藏
页码:1576 / 1582
页数:7
相关论文
共 30 条
[1]   No more free lunches - Patients will benefit from doctors and drug companies disentangling [J].
Abbasi, K ;
Smith, R .
BRITISH MEDICAL JOURNAL, 2003, 326 (7400) :1155-1156
[2]  
Altisent R, 2003, Aten Primaria, V32, P106, DOI 10.1157/13049168
[3]  
*AM MED STUD ASS, AMSAS PHARMFREE CAMP
[4]  
[Anonymous], 2005, Rev. méd. Chile, V133, P607
[5]  
Armas M Rodolfo, 2005, Rev. chil. pediatr., V76, P237
[6]  
*ASILFA, COD ET
[7]  
Borzone T. Gisella, 2003, Rev. chil. enferm. respir., V19, P206
[8]   Pens and other pharmaceutical industry gifts [J].
Brody, H .
AMERICAN JOURNAL OF BIOETHICS, 2003, 3 (03) :58-60
[9]  
*COL MED CHIL, 2004, NUEV COD ET COL MED
[10]   Physician-industry relations. Part 1: Individual physicians [J].
Coyle, SL .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (05) :396-402